Nature Medicine, Published online: 09 October 2025; doi:10.1038/s41591-025-04000-2
A clinical trial of pregnant women provides critical safety and immunogenicity data in support of a two-dose Ebola vaccine regimen — and reinforces the importance of maternal immunization research, urgently needed for other preventable diseases.
